ARTICLE | Clinical News
BNC105: Additional Phase I/II data
June 17, 2013 7:00 AM UTC
Additional data from 12 patients with metastatic RCC who failed prior tyrosine kinase inhibitor (TKI) therapy in the Phase I portion of the open-label, dose-escalation, international Phase I/II Disrup...